Cases 11 - 20 of 73
Forest Laboratories, LLC et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv01287
Plaintiff:
Forest Laboratories, LLC and Forest Laboratories Holdings, Ltd.
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv01129
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al
as 2:2017cv03387
Plaintiff:
CELGENE CORPORATION
Defendant:
HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv00420
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv00375
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Breckenridge Pharmaceutical, Inc. et al
as 1:2017cv00302
Plaintiff:
Pfizer Inc. , PF Prism C.V. and C.P. Pharmaceuticals International C.V.
Defendant:
Breckenridge Pharmaceutical, Inc., Pensa Pharma S.A. and Laboratorios del Dr. Esteve, S.A.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv00019
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc.
as 1:2016cv01001
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP. et al
as 1:2016cv07346
Plaintiff:
OTSUKA PHARMACEUTICAL CO., LTD.
Defendant:
STASON INDUSTRIAL CORP., STASON PHARMACEUTICALS INC., ZHEJIANG JINHUA CONBA BIO-PHARM CO., LTD and others
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Breckenridge Pharmaceutical Inc.
as 1:2016cv00927
Plaintiff:
Amgen Inc.
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
